Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Linden, Peter K.
1998.
Clinical implications of nosocomial gram-positive bacteremia and superimposed antimicrobial resistance.
The American Journal of Medicine,
Vol. 104,
Issue. 5,
p.
24S.
DAS, IRA
and
GRAY, JAMES
1998.
Enterococcal bacteremia in children: a review of seventy-five episodes in a pediatric hospital.
The Pediatric Infectious Disease Journal,
Vol. 17,
Issue. 12,
p.
1154.
Linden, Peter
1999.
Quinupristin-dalfopristin.
Current Infectious Disease Reports,
Vol. 1,
Issue. 5,
Perl, Trish M
1999.
The threat of vancomycin resistance.
The American Journal of Medicine,
Vol. 106,
Issue. 5,
p.
26.
Linden, PeterK
and
Miller, CaroleB
1999.
Vancomycin-resistant Enterococci: the clinical effect of a common nosocomial pathogen.
Diagnostic Microbiology and Infectious Disease,
Vol. 33,
Issue. 2,
p.
113.
Barie, Philip S.
2000.
Editorial:Enterococcusin Perspective.
Surgical Infections,
Vol. 1,
Issue. 2,
p.
91.
Tokars, Jerome I.
Miller, Elaine R.
Alter, Miriam J.
and
Arduino, Matthew J.
2000.
National Surveillance of Dialysis‐Associated Diseases in the United States, 1997.
Seminars in Dialysis,
Vol. 13,
Issue. 2,
p.
75.
Mylotte, J. M.
and
Tayara, A.
2000.
Staphylococcus aureus Bacteremia: Predictors of 30-Day Mortality in a Large Cohort.
Clinical Infectious Diseases,
Vol. 31,
Issue. 5,
p.
1170.
Bhavnani, Sujata M.
Drake, Julie A.
Forrest, Alan
Deinhart, June A.
Jones, Ronald N.
Biedenbach, Douglas J.
and
Ballow, Charles H.
2000.
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia☆.
Diagnostic Microbiology and Infectious Disease,
Vol. 36,
Issue. 3,
p.
145.
Mylotte, J. M.
Graham, R.
Kahler, L.
Young, L.
and
Goodnough, S.
2000.
Epidemiology of Nosocomial Infection and Resistant Organisms in Patients Admitted for the First Time to an Acute Rehabilitation Unit.
Clinical Infectious Diseases,
Vol. 30,
Issue. 3,
p.
425.
Lefort, Agnes
Mainardi, Jean-Luc
Tod, Michel
and
Lortholary, Olivier
2000.
ANTIENTEROCOCCAL ANTIBIOTICS.
Medical Clinics of North America,
Vol. 84,
Issue. 6,
p.
1471.
Chien, J. W.
Kucia, M. L.
and
Salata, R. A.
2000.
Use of Linezolid, an Oxazolidinone, in the Treatment of Multidrug-Resistant Gram-Positive Bacterial Infections.
Clinical Infectious Diseases,
Vol. 30,
Issue. 1,
p.
146.
Winston, D. J.
Emmanouilides, C.
Kroeber, A.
Hindler, J.
Bruckner, D. A.
Territo, M. C.
and
Busuttil, R. W.
2000.
Quinupristin/Dalfopristin Therapy for Infections Due to Vancomycin-Resistant Enterococcus faecium.
Clinical Infectious Diseases,
Vol. 30,
Issue. 5,
p.
790.
Garbutt, J. M.
Ventrapragada, M.
Littenberg, B.
and
Mundy, L. M.
2000.
Association Between Resistance to Vancomycin and Death in Cases of Enterococcus faecium Bacteremia.
Clinical Infectious Diseases,
Vol. 30,
Issue. 3,
p.
466.
Talon, D.
Bertrand, X.
and
Thouverez, M.
2001.
Facteurs de risque et prévention de l'acquisition et de la transmission des entérocoques résistants aux glycopeptides.
Pathologie Biologie,
Vol. 49,
Issue. 8,
p.
641.
Mylotte, Joseph M.
Kahler, Lucinda
and
McCann, Carole
2001.
Community-acquired bacteremia at a teaching versus a nonteaching hospital: Impact of acute severity of illness on 30-day mortality.
American Journal of Infection Control,
Vol. 29,
Issue. 1,
p.
13.
Zaidi, Mussaret
Sifuentes-Osornio, José
Rolón, Ana Lilia
Vázquez, Gabriela
Rosado, Rilke
Sánchez, Mauro
Calva, Juan J
and
de León-Rosales, Samuel Ponce
2002.
Inadequate Therapy and Antibiotic Resistance. Risk Factors for Mortality in the Intensive Care Unit.
Archives of Medical Research,
Vol. 33,
Issue. 3,
p.
290.
Peres-Bota, Daliana
Rodriguez, Hector
Dimopoulos, George
DaRos, Alessandra
Mélot, Christian
Struelens, Marc J
and
Vincent, Jean-Louis
2003.
Are infections due to resistant pathogens associated with a worse outcome in critically ill patients?.
Journal of Infection,
Vol. 47,
Issue. 4,
p.
307.
Nannini, Esteban C.
and
Murray, Barbara E.
2004.
Reemergence of Established Pathogens in the 21st Century.
p.
155.
Gilad, J.
Eskira, S.
Schlaeffer, F.
Vorobiov, M.
Marcovici, A.
Tovbin, D.
Zlotnik, M.
and
Borer, A.
2005.
Surveillance of chronic haemodialysis-associated infections in southern Israel.
Clinical Microbiology and Infection,
Vol. 11,
Issue. 7,
p.
547.